Rare Disease

Case Study: Phase 3 Ultra-Rare Pediatric Trial in Classic Galactosemia

Clinical Trials

Case Study: Early Genotype Confirmation Rescued a Phase 1-2 SCID Trial

Clinical Trials - Oncology

Global Phase 1–2 ROS1 Inhibitor Case Study in NSCLC: Precision’s Path to Zero Data Issues Across 60+ Sites

Clinical Trials

Top Clinical Research Organizations for Rare Diseases in 2025

Clinical Trials - Oncology

Clinical Trial Trends: Early Phase Rare Oncology 

Oncology

Clinical Trial Trends: Rare Oncology vs Non-Oncology

Lessons Learned from a Rare Pediatric Case Study

Clinical Trial Trends: Rare Cardiovascular

Clinical Trial Trends: Rare Autoimmune

Clinical Trial Trends: Rare Oncology

Clinical Trial Trends: Rare Metabolic

Clinical Trial Trends: Rare Pediatric

Translational Research - Biomarkers

Precision Medicine in Pediatrics: Biomarkers and Assay Development

Clinical Trials - Early Phase Research

Clinical Trial Patient Recruitment: Why Concierge Services are a Game-Changer

Clinical Trials - Regulatory

FDA Guidance on Pediatric Drug Development

Clinical Trials - Regulatory

Overcoming Hurdles in Rare Disease Research and Development

Clinical Trials

Decentralized Clinical Trials: Strategies that Work in Rare Diseases

Clinical Trials

FDA Procedural Guidance: Expansion Cohorts in FIH Oncology Clinical Trials